Fenwick Represents Arbital Health in $31M Series B Funding

Fenwick represented Arbital Health, a healthcare technology company, in its $31 million Series B funding. The round was led by Valtruis with participation from existing investors Transformation Capital, Shaper Capital, and Healthy Ventures.

Arbital Health will use the funds to grow its market-leading actuarial team, enhance the company’s benchmarking capabilities, and expand the company’s AI-powered platform to help accelerate the shift to value-based care in the U.S. Additional information can be obtained here.

The Fenwick transaction team was led by corporate partners Michael Esquivel and Aaron Ginsburg and included associates Angelo Angelino and Molly Kearnan.